Molecular identification of zygomycetes from culture and experimentally infected tissues

Journal of Clinical Microbiology

Volumn 44, Issue 2, 2006, Pages 340-349

  Schwarz, Patrick ^a   Bretagne, Stéphane ^a,b   Gantier, Jean Charles ^a   Garcia Hermoso, Dea ^a   Lortholary, Olivier ^a,c   Dromer, Françoise ^a   Dannaoui, Eric ^a,c  

^a INSTITUT PASTEUR   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERNAL TRANSCRIBED SPACER; RIBOSOME DNA;

ABSIDIA; ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE MODEL; DNA EXTRACTION; DNA SEQUENCE; EVALUATION; FEMALE; FREEZING; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; INTRASPECIFIC VARIATION; MOUSE; MUCOR; MUCOR CIRCINELLOIDES; MUCOR INDICUS; MUCORMYCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RELIABILITY; RHIZOMUCOR; RHIZOMUCOR PUSILLUS; RHIZOPUS; RHIZOPUS MICROSPORUS; RHIZOPUS ORYZAE; SEQUENCE ANALYSIS; SPECIES DIFFERENCE; SPECIES IDENTIFICATION; VALIDATION PROCESS; ZYGOMYCETES;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CULTURE MEDIA; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; MICE; MOLECULAR SEQUENCE DATA; MUCORALES; MUCORMYCOSIS; MYCOLOGICAL TYPING TECHNIQUES; RNA, RIBOSOMAL, 5.8S; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY; ZYGOMYCOTA;

ABSIDIA; ANIMALIA; FUNGI; MUCOR; MUCOR CIRCINELLOIDES; MUCOR INDICUS; RHIZOMUCOR; RHIZOMUCOR PUSILLUS; RHIZOPUS; RHIZOPUS MICROSPORUS; RHIZOPUS ORYZAE; ZYGOMYCETES;

EID: 32344432286     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.2.340-349.2006     Document Type: Article

References (34)

1. Abe, A., T. Sone, I. N. Sujaya, K. Saito, Y. Oda, K. Asano, and F. Tomita. 2003. rDNA ITS sequence of Rhizopus oryzae: its application to classification and identification of lactic acid producers. Biosci. Biotechnol. Biochem. 67:1725-1731.
2. Anstead, G. M., D. A. Sutton, E. H. Thompson, I. Weitzman, R. A. Otto, and S. K. Ahuja. 1999. Disseminated zygomycosis due to Rhizopus schipperae after heatstroke. J. Clin. Microbiol. 37:2656-2662.
3. Chakrabarti, A., A. Ghosh, G. S. Prasad, J. K. David, S. Gupta, A. Das, V. Sakhuja, N. K. Panda, S. K. Singh, S. Das, and T. Chakrabarti. 2003. Apophysomyces elegans: an emerging zygomycete in India. J. Clin. Microbiol. 41:783-788.
4. Council of the European Communities. 1986. Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official Journal of the European Communities. L 358, 18/12/1986, p. 0001-0028. Council of the European Communities, Brussels, Belgium.
5. Dannaoui, E., J. F. Meis, D. Loebenberg, and P. E. Verweij. 2003. Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob. Agents Chemother. 47:3647-3650.
6. Dannaoui, E., J. F. Meis, J. W. Mouton, and P. E. Verweij. 2002. In vitro susceptibilities of Zygomycota to polyenes. J. Antimicrob. Chemother. 49: 741-744.
7. Dannaoui, E., J. Meletiadis, J. W. Mouton, J. F. Meis, and P. E. Verweij. 2003. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J. Antimicrob. Chemother. 51:45-52.
8. de Hoog, G. S., and J. Guarro (ed.). 1995. Atlas of clinical fungi. Centraalbureau voor Schimmelcultures, Baarn, The Netherlands.
9. Dromer, F., and M. R. McGinnis. 2002. Zygomycosis, p. 297-308. In M. A. Pfaller (ed.), Clinical mycology. Churchill Livingstone, New York, N.Y.
10. Espinel-Ingroff, A. 1998. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J. Clin. Microbiol. 36:2950-2956.
11. Gerrits van den Ende, A. H. G., and G. S. de Hoog. 1999. Variability and molecular diagnostics of the neurotropic species Cladophialophora bantiana. Stud. Mycol. 43:151-162.
12. Greenberg, R. N., L. J. Scott, H. H. Vaughn, and J. A. Ribes. 2004. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr. Opin. Infect. Dis. 17:517-525.
13. Hall, L., S. Wohlfiel, and G. D. Roberts. 2004. Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of filamentous fungi encountered in the clinical laboratory. J. Clin. Microbiol. 42:622-626.
14. Hebert, P. D. N., S. Ratnasingham, and J. R. DeWaard. 2003. Barcoding animal life: cytochrome c oxidase subunit 1 divergences among closely related species. Proc. R. Soc. Lond. B 270:S596-S599.
15. Imhof, A., S. A. Balajee, D. N. Fredricks, J. A. Englund, and K. A. Marr. 2004. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin. Infect. Dis. 39:743-746.
16. Iwen, P. C., S. H. Hinrichs, and M. E. Rupp. 2002. Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Med. Mycol. 40:87-109.
17. Kontoyiannis, D. P., M. S. Lionakis, R. E. Lewis, G. Chamilos, M. Healy, C. Perego, A. Safdar, H. Kantarjian, R. Champlin, T. J. Walsh, and I. I. Raad. 2005. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J. Infect. Dis. 191:1350-1360.
18. Kontoyiannis, D. P., V. C. Wessel, G. P. Bodey, and K. V. Rolston. 2000. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin. Infect. Dis. 30:851-856.
19. Kress, W. J., K. J. Wurdack, E. A. Zimmer, L. A. Weigt, and D. H. Janzen. 2005. Use of DNA barcodes to identify flowering plants. Proc. Natl. Acad. Sci. USA 102:8369-8374.
20. Kwok, S., and R. Higuchi. 1989. Avoiding false positives with PCR. Nature 339:237-238.
21. Kwon-Chung, K. J., and J. E. Bennett. 1992. Medical mycology. Lea & Febiger, Philadelphia, Pa.
22. Marr, K. A., R. A. Carter, F. Crippa, A. Wald, and L. Corey. 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34:909-917.
23. Marty, F. M., L. A. Cosimi, and L. R. Baden. 2004. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N. Engl. J. Med. 350:950-952.
24. Ribes, J. A., C. L. Vanover-Sams, and D. J. Baker. 2000. Zygomycetes in human disease. Clin. Microbiol. Rev. 13:236-301.
25. Ruchel, R., and M. Schaffrinski. 1999. Versatile fluorescent staining of fungi in clinical specimens by using the optical brightener Blankophor. J. Clin. Microbiol. 37:2694-2696.
26. Schipper, M. A., M. M. Maslen, G. G. Hogg, C. W. Chow, and R. A. Samson. 1996. Human infection by Rhizopus azygosporus and the occurrence of azygospores in zygomycetes. J. Med. Vet. Mycol. 34:199-203.
27. Scholer, H. J., E. Müller, and M. A. A. Schipper. 1983. Mucorales, p. 9-59. In D. H. Howard (ed.), Fungi pathogenic for humans and animals, part A. Biology. Marcel Dekker, New York, N.Y.
28. Siwek, G. T., K. J. Dodgson, M. De Magalhaes-Silverman, L. A. Bartelt, S. B. Kilborn, P. L. Hoth, D. J. Diekema, and M. A. Pfaller. 2004. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin. Infect. Dis. 39:584-587.
29. Sun, Q. N., A. W. Fothergill, D. I. McCarthy, M. G. Rinaldi, and J. R. Graybill. 2002. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob. Agents Chemother. 46:1581-1582.
30. Sun, Q. N., L. K. Najvar, R. Bocanegra, D. Loebenberg, and J. R. Graybill. 2002. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob. Agents Chemother. 46:2310-2312.
31. Voigt, K., E. Cigelnik, and K. O'Donnell. 1999. Phylogeny and PCR identification of clinically important Zygomycetes based on nuclear ribosomal-DNA sequence data. J. Clin. Microbiol. 37:3957-3964.
32. Voigt, K., and J. Wostemeyer. 2001. Phylogeny and origin of 82 zygomycetes from all 54 genera of the Mucorales and Mortierellales based on combined analysis of actin and translation elongation factor EF-1alpha genes. Gene 270:113-120.
33. Weitzman, I., S. Whittier, J. C. McKitrick, and P. Della-Latta. 1995. Zygospores: the last word in identification of rare or atypical zygomycetes isolated from clinical specimens. J. Clin. Microbiol. 33:781-783.
34. Zheng, R. Y., and G. Q. Chen. 1993. Another non-thermophilic Rhizomucor causing human primary cutaneous mucormycosis. Mycosystema 6:1-12.